Lawrence M Scala, MD
Radiation Oncology · Santa Clara
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 4
- 1 carrier
- Offices
- 2
- Since medical school
- 20 years
- Graduated 2006
Offices
2 locations · Permanente Medical Group Inc · 10,928 clinicians in this group
Plans that list them
4 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Scala’s office at (408) 851-1000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Kaiser Permanente Dual Complete North P2 (HMO D-SNP) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Dual Complete North P23 (HMO D-SNP) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Sr Adv Basic Santa Clara (HMO) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Sr Adv Enhanced Santa Clara (HMO) | Kaiser Permanente | Listed | Sep 1, 2026 |
California Medical Board record
Licence A103489 · Current
Licensed to practise in California · since 2008 · expires 2028-01-31 · Umdnj New Jersey Medical School.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Radiology - Radiation Oncology
Drugs they prescribed that Part D paid
$4,962
Pharmacies billed $4,962 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
263 generic and fewer than 11 brand-name prescriptions · $4,962 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Tamsulosin | 174 | $2,837 | $16 |
| Trospium Chloride | 13 | $450 | $35 |
| Gavilyte-C | 14 | $314 | $22 |
| Oxybutynin Chloride | 15 | $267 | $18 |
| Bicalutamide | 12 | $247 | $21 |
Year by year
| 2024 | 264 | 100 | None | None | $4,962 |
| 2023 | 285 | 111 | None | None | $5,648 |
| 2022 | 385 | 133 | None | None | $7,802 |
| 2021 | 350 | 122 | None | 3% | $7,699 |
| 2020 | 352 | 110 | None | 4% | $8,549 |
| 2019 | 341 | 113 | None | None | $11,208 |
| 2018 | 364 | 109 | None | 6% | $10,625 |
| 2017 | 329 | 90 | 4% (13) | None | $8,316 |
| 2016 | 208 | 74 | None | None | $7,778 |
| 2015 | 135 | 63 | None | None | $4,095 |
| 2014 | 81 | 43 | None | None | $3,793 |
| 2013 | 136 | 48 | 17% (23) | None | $3,129 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 3 drugs
| Tamsulosin | 188 | $3,156 | $17 |
| Gavilyte-C | 23 | $472 | $21 |
| Oxybutynin Chloride | 14 | $275 | $20 |
2022: 5 drugs
| Tamsulosin | 235 | $4,058 | $17 |
| Trospium Chloride | 14 | $455 | $33 |
| Gavilyte-C | 24 | $417 | $17 |
| Oxybutynin Chloride | 18 | $375 | $21 |
| Bicalutamide | 29 | $342 | $12 |
2021: 5 drugs
| Tamsulosin | 220 | $3,659 | $17 |
| Oxybutynin Chloride | 11 | $317 | $29 |
| Bicalutamide | 23 | $315 | $14 |
| Peg-3350 and Electrolytes | 12 | $242 | $20 |
| Gavilyte-C | 11 | $165 | $15 |
2020: 5 drugs
| Tamsulosin | 216 | $4,030 | $19 |
| Megestrol Acetate | 18 | $685 | $38 |
| Oxybutynin Chloride | 11 | $317 | $29 |
| Gavilyte-C | 15 | $282 | $19 |
| Bicalutamide | 19 | $204 | $11 |
2019: 4 drugs
| Tamsulosin | 214 | $4,420 | $21 |
| Gavilyte-C | 36 | $1,284 | $36 |
| Megestrol Acetate | 15 | $524 | $35 |
| Bicalutamide | 16 | $207 | $13 |
2018: 5 drugs
| Tamsulosin | 229 | $4,768 | $21 |
| Peg 3350-Electrolyte | 18 | $652 | $36 |
| Gavilyte-C | 16 | $579 | $36 |
| Megestrol Acetate | 12 | $334 | $28 |
| Bicalutamide | 18 | $279 | $16 |
2017: 3 drugs
| Tamsulosin | 194 | $4,392 | $23 |
| Gavilyte-C | 52 | $884 | $17 |
| Bicalutamide | 18 | $402 | $22 |
2016: 3 drugs
| Tamsulosin | 112 | $4,629 | $41 |
| Gavilyte-C | 29 | $517 | $18 |
| Alfuzosin Hcl Er | 11 | $441 | $40 |
2015: 2 drugs
| Tamsulosin | 66 | $2,464 | $37 |
| Gavilyte-C | 36 | $612 | $17 |
2014: 1 drug
| Tamsulosin | 36 | $960 | $27 |
2013: 3 drugs
| Tamsulosin | 52 | $1,107 | $21 |
| Hydrocodone-Acetaminophen | 18 | $401 | $22 |
| Lidocaine Hcl Viscous | 11 | $237 | $22 |
Professional record
- NPI
- 1487828539
- Licence
- CA A103489California A103489: Current · expires 2028-01-31
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 2085R0001X (2085R0001X)
- Mailing address
- 2333 Buchanan St, Level B, San Francisco, CA, 94115
- NPI first listed
- 2008-04-19
- NPI last updated
- 2021-12-22
This is when the NPI record was last certified, not a medical board exam.
This office lists an electronic records connection.